Skip to main content

previous disabled Page of 4
and
Your search also matched 11 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

TBC1D10B promotes tumor progression in colon cancer via PAK4‑mediated promotion of the PI3K/AKT/mTOR pathway

Include preview-only content
  1. Article

    Open Access

    Prognostic value of the Naples prognostic score in patients with intrahepatic cholangiocarcinoma after hepatectomy

    The Naples Prognostic Score (NPS), integrating inflammatory and nutritional biomarkers, has been reported to be associated with the prognosis of various malignancies, but there is no report on intrahepatic cho...

    Cheng-Fei Du, Zhen-Yu Gao, Zhu-Ding Xu, Zheng-Kang Fang, Zi-Chen Yu in BMC Cancer (2024)

  2. Article

    Open Access

    CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis via the miR-455-3p/NUPR1/FTH1 axis

    The role of circRNAs in hepatocellular carcinoma (HCC) progression remains unclear. CircPIAS1 (circBase ID: hsa_circ_0007088) was identified as overexpressed in HCC cases through bioinformatics analysis. This ...

    **ao-Yu Zhang, Shan-Shan Li, Yu-Rong Gu, Le-**n **ao, **n-Yi Ma in Molecular Cancer (2024)

  3. Article

    Open Access

    The selective sponging of miRNAs by OIP5-AS1 regulates metabolic reprogramming of pyruvate in adenoma-carcinoma transition of human colorectal cancer

    RNA interactomes and their diversified functionalities have recently benefited from critical methodological advances leading to a paradigm shift from a conventional conception on the regulatory roles of RNA in...

    **g-Yu Wang, **ao-** Zhang, Hong-Kun Zhou, Hong-**n Cai, **-Biao Xu in BMC Cancer (2024)

  4. Article

    Open Access

    Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia

    The C-reactive protein (CRP)-triglyceride-glucose (TyG) index (CTI), which is a measure representing the level of inflammation and insulin resistance (IR), is related to poor cancer prognosis; however, the CTI...

    Guo-Tian Ruan, Li Deng, Hai-Lun **e, **-Yu Shi, **ao-Yue Liu in Cancer & Metabolism (2024)

  5. Article

    Open Access

    Mutation status of the KMT2 family associated with immune checkpoint inhibitors (ICIs) therapy and implicating diverse tumor microenvironments

    Mounting evidence suggests a strong association between tumor immunity and epigenetic regulation. The histone-lysine N-methyltransferase 2 (KMT2) family plays a crucial role in the methylation of histone H3 at...

    Dong-Xu Wang, Jun-Yu Long, Rui-Zhe Li, Dao-Lin Zhang, Hui Liu in Molecular Cancer (2024)

  6. Article

    Open Access

    Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2

    The aim of this study is to evaluate an AAV vector that can selectively target breast cancer cells and to investigate its specificity and anti-tumor effects on breast cancer cells both in vitro and in vivo, of...

    Ya-feng Lv, Hao Zhang, Zhi Cui, Cui-jiao Ma, Yu-ling Li, Hua Lu, Hong-yan Wu in BMC Cancer (2023)

  7. Article

    Open Access

    Retraction Note: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo

    Yu-Yin Xu, Li Chen, Gui-Lan Wang, Jia-Ming Zhou, Yi-**n Zhang, Yin-Ze Wei in BMC Cancer (2023)

  8. Article

    Open Access

    Integrated analysis of intratumoral biomarker and tumor-associated macrophage to improve the prognosis prediction in cancer patients

    The lack of effective and accurate predictive indicators remains a major bottleneck for the improvement of the prognosis of patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Hepatit...

    Ming-Da Wang, Hao **ang, Tian-Yu Hong, Abudurexiti Mierxiati, Fei-Hu Yan in BMC Cancer (2023)

  9. Article

    Open Access

    Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer

    Increasing evidence indicates that the tumor microenvironment (TME) is a crucial determinant of cancer progression. However, the clinical and pathobiological significance of stromal signatures in the TME, as a...

    Jian-Zhong He, Yang Chen, Fa-Min Zeng in Journal of Experimental & Clinical Cancer … (2023)

  10. Article

    Open Access

    Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia

    Acute myeloid leukemia (AML) is a myeloid neoplasm makes up 7.6% of hematopoietic malignancies. Super-enhancers (SEs) represent a special group of enhancers, which have been reported in multiple cell types. In...

    Fang Fang, Jun Lu, Xu Sang, Yan-Fang Tao in Journal of Experimental & Clinical Cancer … (2022)

  11. Article

    Open Access

    Current status of neoadjuvant therapy for locally advanced rectal cancer in Wuhan Union Hospital Cancer Center

    To analyze and explore the evolution and short-term efficacy of neoadjuvant therapy for patients with mid and low LARC in Wuhan Union Hospital Cancer Center.

    Meng-Lan Zhai, Fang-Yuan Zhang, **-Ru Yang, Sheng Zhang, Lei Zhao in Radiation Oncology (2022)

  12. Article

    Open Access

    Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma

    Previous in vitro hepatocyte differentiation model showed that TROY was specifically expressed in liver progenitor cells and a small proportion of hepatocellular carcinoma cells, suggesting that TROY may parti...

    Beilei Liu, **aona Fang, Dora Lai-Wan Kwong in Journal of Experimental & Clinical Cancer … (2022)

  13. Article

    Open Access

    Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway

    Triple negative breast cancer (TNBC) is highly malignant and has a worse prognosis, compared with other subtypes of breast cancer due to the absence of therapeutic targets. KIF23 plays a crucial role in the tu...

    Zhi Li, Hai-Yan Yang, **ao-Lan Zhang in Journal of Experimental & Clinical Cancer … (2022)

  14. Article

    Open Access

    Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy

    The role of skeletal muscle index (SMI) and systemic inflammation index (SII) for patients with lymph node-positive breast cancer remain controversial. This retrospective study aims to evaluate the individual ...

    Ru Tang, Jia-Peng Deng, Lei Zhang, Wen-Wen Zhang, Jia-Yuan Sun, Feng Chi in BMC Cancer (2022)

  15. Article

    Open Access

    m6A modification: recent advances, anticancer targeted drug discovery and beyond

    Abnormal N6-methyladenosine (m6A) modification is closely associated with the occurrence, development, progression and prognosis of cancer, and aberrant m6A regulators have been identified as novel anticancer ...

    Li-Juan Deng, Wei-Qing Deng, Shu-Ran Fan, Min-Feng Chen, Ming Qi in Molecular Cancer (2022)

  16. Article

    Open Access

    A novel prognostic index for sporadic Burkitt lymphoma in adult patients: a real-word multicenter study

    Adult sporadic Burkitt lymphoma (BL) is a rare but highly aggressive subtype of lymphoma which lacks its own unique prognostic model. Systemic inflammatory biomarkers have been confirmed as prognostic markers ...

    Mei-ting Chen, Fei Pan, Yung-chang Chen, Wei Zhang, Hui-juan Lv, Zhao Wang in BMC Cancer (2022)

  17. Article

    Open Access

    Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma

    Second head and neck neuroendocrine carcinoma (NEC) after radical radiotherapy for nasopharyngeal carcinoma (NPC) treatment is rarely reported. The prognosis of second cancer is poor, and our research focuses ...

    Ying-peng Peng, Qiao-dan Liu, Yu-**g Lin, Shun-li Peng, Rong Wang in Radiation Oncology (2021)

  18. Article

    Open Access

    Neo-adjuvant radiation therapy provides a survival advantage in T3-T4 nodal positive gastric and gastroesophageal junction adenocarcinoma: a SEER database analysis

    Due to negative results in clinical trials of postoperative chemoradiation for gastric cancer, at present, there is a tendency to move chemoradiation therapy forward in gastric and gastroesophageal junction (G...

    Yu-Jie Zhou, **ao-Fan Lu, Jia-Lin Meng, **n-Yuan Wang, Qing-Wei Zhang in BMC Cancer (2021)

  19. Article

    Open Access

    EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling

    Somatic mutations are involved in hepatocellular carcinoma (HCC) progression, but the genetic mechanism associated to hepatocarcinogenesis remains poorly understood. We report that Eyes absent homolog 2 (EYA2)...

    Ze-Kun Liu, Can Li, Ren-Yu Zhang, Ding Wei, Yu-Kui Shang, Yu-Le Yong in Molecular Cancer (2021)

  20. Article

    Open Access

    Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data

    The clinical staging systems for adenocarcinoma of the esophagogastric junction (AEG) are controversial. We aimed to propose a prognostic nomogram based on real-world data for predicting survival of Siewert ty...

    Jian Chen, Yu-Jian **a, Tian-Yu Liu, Yuan-Hui Lai, Ji-Shang Yu in BMC Cancer (2021)

previous disabled Page of 4